Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1601]

First-line use of tepotinib in METex14 NSCLC: A patient-centered journey

Dr Ryan Nguyen, Rebecca Timogtimog, Carmela Timogtimog

First-line use of tepotinib in METex14 NSCLC: A patient-centered journey ( Dr Ryan Nguyen, Rebecca Timogtimog, Carmela Timogtimog )

Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive...

Prof Robert Orlowski - The University of Texas MD Anderson Cancer Center...

Linvoseltamab monotherapy in newly diagnosed multiple myeloma shows impressive frontline responses ( Prof Robert Orlowski - The University of Texas MD Anderson Cancer Center, Houston, USA )

Empowering cancer care in Africa

Prof Cesaltina Ferreira Lorenzoni - Mozambican Ministry of Health, Maputo...

Empowering cancer care in Africa ( Prof Cesaltina Ferreira Lorenzoni - Mozambican Ministry of Health, Maputo, Mozambique and AORTIC President )

Latest in bladder cancer from the second half of 2025

Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone...

Latest in bladder cancer from the second half of 2025 ( Dr Alison Birtle, Dr Ignacio Durán, Prof Evanguelos Xylinas, Dr Giuseppe Simone and Dr Enrique Grande )

Principles and practice of prognostication

Dr Martin Stockler Sydney University, Sydney, Australia

Principles and practice of prognostication ( Dr Martin Stockler Sydney University, Sydney, Australia )

Optimal management of gastric cancers

Dr Prasanth Penumadu - Institution of Cancer Care & Advanced Research...

Optimal management of gastric cancers ( Dr Prasanth Penumadu - Institution of Cancer Care & Advanced Research , Tirupati, India. )

Temab-A plus bevacizumab shows promising response rates in advanced colorectal...

Dr Michael Cecchini - Yale School of Medicine, New Haven, USA

Temab-A plus bevacizumab shows promising response rates in advanced colorectal cancer ( Dr Michael Cecchini - Yale School of Medicine, New Haven, USA )

ESMO 2025: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2025: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )

PRAME-targeted TCR therapy shows high response rates in metastatic uveal...

Dr Sapna Patel - University of Colorado Anschutz, Aurora, USA

PRAME-targeted TCR therapy shows high response rates in metastatic uveal melanoma ( Dr Sapna Patel - University of Colorado Anschutz, Aurora, USA )

Trastuzumab deruxtecan demonstrates advance in treatment for HER2-positive...

Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA

Trastuzumab deruxtecan demonstrates advance in treatment for HER2-positive gastric cancer ( Dr Yelena Janjigian - Memorial Sloan Kettering Cancer Center, New York, USA )

Low-dose pembrolizumab plus neoadjuvant chemo option for TNBC in resource...

Dr Atul Batra - All India Institute Of Medical Sciences Delhi, New Delhi, India

Low-dose pembrolizumab plus neoadjuvant chemo option for TNBC in resource-constrained settings ( Dr Atul Batra - All India Institute Of Medical Sciences Delhi, New Delhi, India )

Proton vs photon radiotherapy shows similar patient-reported quality of life in...

Dr Shannon MacDonald - Southwest Florida Proton Center, Florida, USA

Proton vs photon radiotherapy shows similar patient-reported quality of life in breast cancer patients ( Dr Shannon MacDonald - Southwest Florida Proton Center, Florida, USA )

More from ecancer